Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors [NA]

View source ↗

Summary

A recruiting study evaluating pancreatic radiofrequency ablation under endoscopic ultrasound guidance for pancreatic neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1 | NA | Status: RECRUITING